Neuroscience & Neurodegenerative Disease Biospecimens
Neuroscience & Neurodegenerative
Disease Biospecimens
Accelerate your research into Alzheimer’s disease, Parkinson’s
disease and other neurological disorders with premium-quality
samples and rich clinical annotation
Access a comprehensive portfolio of neuroscience-focused biospecimens
Our donor network across the United States supports research into major neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and a broad range of other neurological conditions. Whether you need cross-sectional or longitudinal collections, matched sample sets, or custom cohorts, we provide the precise specimens and deep annotation required for breakthrough neuroscience research.
Why Choose Sanguine for Neuro Disease Specimen Solutions
Neurodegenerative disease research demands high-quality biospecimens, rigorous donor annotation, and compliance with ethical standards.
Direct-to-donor model & engaged donor network
Our nationwide network allows access to well-characterized donors, streamlining procurement so you can focus on discovery.
Custom collection services
If what you need isn’t available in
our inventory, we will recruit and collect from a custom cohort tailored to your specific inclusion/exclusion criteria.
Access to hard-to-find populations
Neurodegenerative disease states,
early vs late stage, treatment-naïve
vs treated — we work with you to
source the right donors.
Matched sample sets
Get multiple sample types from the same donor (e.g., blood, PBMC) for holistic biomarker analysis.
Comprehensive clinical & molecular annotation
Receive samples paired with rich donor data — demographics, disease history, treatment and outcomes, and imaging when available.
Ethical sourcing & regulatory compliance
Our processes meet high ethical and data-security standards (ISO certifications, data privacy) which gives you confidence in your
research tools
Neuro Disease Specimen Portfolio
Available specimen types include:
Plasma & serum
Whole blood & PBMCs
Longitudinal (serial) collections to track disease progression and response to intervention
Rich clinical and molecular annotation:
Many of our neuroscience biospecimens come with detailed donor documentation, enabling them to function as true translational
research tools.
Demographics & clinical characteristics
Diagnosis and stage, age at onset, gender, race/ethnicity, family history, comorbidities
Treatment history
Medication exposures (e.g., dopamine agonists, cholinesterase inhibitors), surgical interventions (e.g., DBS), other therapie
Molecular profiling
Where available, data may include biomarker levels (e.g., alpha synuclein, tau, neurofilament light chain), genetic or genomic data, copy number variation, gene expression profiles
Outcomes data
Progression rates, cognitive/functional decline metrics, treatment response, longitudinal follow-up
Ethical Sourcing and Regulatory Compliance
Trust and compliance are fundamental to our operations.
Ethical standards:
- Institutional Review Board (IRB)-approved donor consent documentation
- Donors engaged through transparent, compliant recruitment and consent processes
Regulatory & data security: - De-identified donor data in HIPAA-compliant format
- Certified quality management systems including ISO 9001, ISO 27001, ISO 27701 for information security and privacy. PR Newswire+1
From Discovery to Therapy — Powering Every Step of Neuro Research
Whether you’re exploring disease pathogenesis, developing diagnostics, or validating therapeutic strategies, our biospecimens supportresearch across the neuroscience continuum:
Basic research
Investigate mechanisms of neurodegeneration, synaptic dysfunction, protein aggregation (e.g., tau, alpha-synuclein)
Biomarker discovery & validation
Use longitudinal sets and matched controls to identify prognostic or predictive markers (e.g., neurofilament light chain, imaging correlates)
Therapeutic development
Support drug discovery and clinical validation with well-characterized donor samples, treatment-naïve and treated cohorts
Precision neuroscience
Leverage genomic profiling in samples linked to phenotypic and outcomes data to enable precision medicine approaches
Diagnostics development
Develop and validate assays for early detection or progression of Alzheimer’s, Parkinson’s or other neurodegenerative diseases
Ready to Advance Your Neurodegenerative Disease Research?
Our donor network across the United States supports research into major neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and a broad range of other neurological conditions. Whether you need cross-sectional or longitudinal collections, matched sample sets, or custom cohorts, we provide the precise specimens and deep annotation required for breakthrough neuroscience research.